This is the first report of an Acinetobacter baumannii from clinical origin carrying the bla OXA-58 gene in Brazil. The isolate included in this study was from a patient during an outbreak in Porto Alegre, RS, Southern Brazil, in 2007. It was resistant to most of the beta-lactams tested, it has also the bla OXA-65 gene and the ISAba1 sequence located upstream to both bla OXA genes detected and it has a MIC of imipenem of 64 g/mL.
The nosocomial infections caused by A. baumannii have been the target of intense research in recent years due to their great ability to rapidly acquire resistance to the drugs of choice used in antimicrobial therapy. The most common mechanism of drug resistance in these bacteria is the expression of OXAcarbapenemases, a class D carbapenem-hidrolysing--lactamase (1, 5, 12) . Currently, there are four families of OXA carbapenemases in Acinetobacter sp.: OXA-23-like, OXA-24-like, OXA-58-like and OXA-51-like enzymes, the last being intrinsic to A. baumannii (9, 17) . In addition, the presence of the insertion sequence ISAba1 immediately upstream of the bla OXA-51 gene contributes to increased expression of resistance to carbapenems, since the presence of this gene is not necessarily related to resistance (20, 21) .
Only carbapenemases OXA-23-like and OXA-51-like have been found in Brazil, so far (3, 6, 13) . Carbapenemases OXA-58 were first described in Europe, where they are widely disseminated (15, 18) . In South America, the presence of the gene was described in Argentina, commonly associated with resistance to carbapenems in Acinetobacter sp. outbreaks (5, 17) . The occurrence of this carbapenemase has also been observed in Asia, showing that it is widely distributed throughout the world (5, 9, 17) . Unlike bla OXA-23 and bla genes, broadly found across the country in different strains (13, 19) , the bla OXA-58 gene has not been described in Brazil.
In a previous study (8) , 74 clinical isolates were tested for their antimicrobial susceptibility and the presence of bla OXA-23-like , bla OXA-24-like , bla OXA-51-like and bla OXA-58-like genes. The (Figure 1a and 1b) . (Figure 1a and 1b) .
Sequencing analysis of the bla OXA-51-like-all PCR product showed 99% homology with bla OXA-65 gene. The enzyme OXA-65 was first described in two isolates from Argentina and has 98% identity with OXA-51, thus belonging to the same subgroup primarily described in 2005 (2).
To our knowledge, for the first time in Brazil, a positive result was obtained for bla gene and the sequencing analysis showed 100% homology with the bla OXA-58 gene of A.
baumannii. This enzyme was first described in France in an outbreak of hospital infection in 2003 and since then it has been found around the world. Corroborating with previous studies, this finding confirms the worldwide spread of the OXA-58 carbapenemase (15, 16) . In South America this enzyme is prevalent and of public health concern in Argentina, a neighboring country to Rio Grande do Sul State, where the present study was conducted. In Argentina, in contrast to our findings, the MICs observed for imipenem were from 8 to 32µg/mL, indicating a low level of resistance to this antibiotic (5, 14) . However, our results suggested that additional mechanisms of resistance may be present, since the MIC was higher. In the present study, the ISAba1 sequence is located upstream to both bla OXA-65 and bla OXA-58 genes (Figure 1a and 1b), therefore, its presence may be associated with the increased level of resistance observed (MIC = 64 g/mL). As previously described, this IS, when located upstream to bla OXA-51-like , may play a role of promoter and enhance resistance to carbapenems (10, 20, 21 
